Delgado-Enciso I, Guzmán-Esquivel J

Language: Spanish
References: 6
Page: 1-3
PDF size: 91.09 Kb.

Text Extraction

No abstract.

REFERENCES

1. Guzman-Esquivel J, Murillo-Zamora E, Ortiz-Mesina M, Galvan-Salazar HR, De-Leon-Zaragoza L, Casarez-Price JC, et al. Regionaland national burden of prostate cancer:incidence, mortality, years of life lost, anddisability-adjusted life years, in Mexico andLatin America from 1990 to 2019. InternationalUrology and Nephrology. 2023;55(9): 2155–2160.https://doi.org/10.1007/s11255-023-03653-7

2. Naghavi M, Ong KL, Aali A, Ababneh HS, AbateYH, Abbafati C, et al. Global burden of 288 causesof death and life expectancy decomposition in204 countries and territories and 811 subnationallocations, 1990–2021: a systematic analysis forthe Global Burden of Disease Study 2021. TheLancet. 2024;403(10440): 2100–2132. https://doi.org/10.1016/S0140-6736(24)00367-2.

3. Wang L, Lu B, He M, Wang Y, Wang Z, Du L.Prostate Cancer Incidence and Mortality: GlobalStatus and Temporal Trends in 89 CountriesFrom 2000 to 2019. Frontiers in Public Health.2022;10: 811044. https://doi.org/10.3389/fpubh.2022.811044.

4. Guzman‑Esquivel J, Mendoza‑HernandezMA, Tiburcio‑Jimenez D, Avila‑Zamora ON,Delgado‑Enciso J, De‑Leon‑Zaragoza L, et al.Decreased biochemical progression in patientswith castration‑resistant prostate cancer usinga novel mefenamic acid anti‑inflammatorytherapy: A randomized controlled trial. OncologyLetters. 2020;19(6): 4151–4160. https://doi.org/10.3892/ol.2020.11509.

5. Rojas-Martínez A, Manzanera AG, SukinSW, Esteban-María J, González-GuerreroJF, Gomez-Guerra L, et al. Intraprostaticdistribution and long-term follow-up after AdVtkimmunotherapy as neoadjuvant to surgeryin patients with prostate cancer. Cancer GeneTherapy. 2013;20(11): 642–649. https://doi.org/10.1038/cgt.2013.56.

6. Ouellet V, Erickson A, on behalf of GAP1UTMAs Contributing Investigators,Wiley K, Morrissey C, Berge V, et al. TheMovember Global Action Plan 1 (GAP1):Unique Prostate Cancer Tissue MicroarrayResource. Cancer Epidemiology, Biomarkers &Prevention. 2022;31(4): 715–727. https://doi.org/10.1158/1055-9965.EPI-21-0600.